½ÃÀ庸°í¼­
»óǰÄÚµå
1602323

¼¼°èÀÇ 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀå : À¯Çüº°, ¿ëµµº°-¿¹Ãø(2025-2030³â)

5G-enabled Medical Devices Market by Type (Implantable Devices, Medical Imaging Equipment, Wearable Devices), Application (Connected Ambulance, HD virtual Consultations, Remote Patient Monitoring) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 8¾ï 676¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 9¾ï 9,110¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 22.92%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 34¾ï 2,084¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

5G ´ëÀÀ ÀÇ·á±â±â´Â ÃÖ÷´Ü Åë½ÅÀ» ÀÇ·á ÇàÀ§¿¡ ÅëÇÕÇÔÀ¸·Î½á ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ º¯ÇõÀû ºñ¾àÀ» »ó¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µð¹ÙÀ̽º´Â 5G ³×Æ®¿öÅ©ÀÇ ¼Óµµ, ÀúÁö¿¬, °í¿¬°á¼ºÀ» Ȱ¿ëÇÏ¿© ¿ø°Ý ¸ð´ÏÅ͸µ, ¿ø°Ý ÀÇ·á, ·Îº¿ ¼ö¼ú, ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®À» °­È­ÇÏ¿© ȯÀÚÀÇ Áï°¢ÀûÀÎ Äɾî¿Í º¸´Ù Á¤È®ÇÑ ÀÇ·á °³ÀÔÀ» ÃËÁøÇÕ´Ï´Ù. 5G ´ëÀÀ ÀÇ·á±â±âÀÇ Çʿ伺Àº Àα¸ÀÇ °í·ÉÈ­¿¡ ´ëÀÀÇϰí, ¸¸¼º ÁúȯÀ» °ü¸®Çϰí, À§±â »óȲ¿¡¼­ÀÇ ÀÀ´ä ½Ã°£À» °³¼±ÇÒ ¼ö ÀÖ´Â È¿À²ÀûÀÎ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¿ëµµ ¹üÀ§´Â º´¿ø, Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ¹× ÀçÅÃÄ¡·á¸¦ Æ÷ÇÔÇÏ¿© Ä¿³ØÆ¼µå ÀÓÇöõÆ®, ÈÞ´ë¿ë Áø´Ü, ¿þ¾î·¯ºí µîÀÇ ÀåÄ¡¸¦ Ȱ¿ëÇÕ´Ï´Ù. ÁÖ¿ä ¼ºÀå ÃËÁø ¿äÀÎÀ¸·Î´Â ±â¼ú Áøº¸, µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç Áõ°¡, ÇコÄɾîÀÇ µðÁöÅÐÈ­¸¦ À§ÇÑ °ü¹Î ½Ö¹æÀ¸·ÎºÎÅÍÀÇ ÅõÀÚ Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ±âȸ´Â ¿ø°Ý ÀÇ·á ¼­ºñ½º È®´ë, °³º°È­ ÀÇ·á, AI ÁÖµµÀÇ Áø´Ü¿¡ ÀÖÀ¸¸ç, À̵éÀº 5G ±â¼úÀ» »ç¿ëÇØ Áõ°­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª °íºñ¿ë, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½ÃÀÇ ¿ì·Á, ÀÎÇÁ¶óÀÇ Á¦ÇÑÀ̶ó°í ÇÏ´Â °úÁ¦°¡ ¼ºÀåÀ» ÀúÇØÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦ »óȲÀº ¿©ÀüÈ÷ º¹ÀâÇϰí Áö¿ª¿¡ µû¶ó ´Ù¸£±â ¶§¹®¿¡ ½Å¼ÓÇÑ µµÀÔÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß¿¡¼­´Â »óÈ£¿î¿ë¼º °­È­, ¸ð¹ÙÀÏ ±â±â¿ë º¸´Ù È¿À²ÀûÀÎ ¹èÅ͸® ¼Ö·ç¼Ç °³¹ß, ¹Î°¨ÇÑ È¯ÀÚ Á¤º¸¸¦ º¸È£Çϱâ À§ÇÑ °­·ÂÇÑ »çÀ̹ö º¸¾È ÇÁ·ÎÅäÄÝ °³¹ß µî¿¡ ÁÖ·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú ÇコÄɾîÀÇ µðÁöÅÐ ÀüȯÀ» À§ÇÑ Á¾ÇÕÀûÀÎ µ¿Çâ¿¡ ÈûÀÔ¾î ¿ªµ¿ÀûÀ¸·Î ¼ºÀåÇϴ ż¼¸¦ Á¤µ·Çϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº Çõ½ÅÀ» ÃßÁøÇϱâ À§ÇÑ Àü·«Àû ÆÄÆ®³Ê½Ê°ú Çù¾÷ »ýŰ迡 ÅõÀÚÇϰí 5G ÀÎÇÁ¶ó°¡ ¹ßÀüÇϰí ÀÖ´Â Áö¿ª¿¡ ÁÖ·ÂÇÔÀ¸·Î½á ÀÚº»À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÇコÄɾî ÁÖü°¡ º¸´Ù ³×Æ®¿öũȭµÇ°í µ¥ÀÌÅÍ ÁÖµµÇü »ê¾÷À¸·Î ÀÌÇàÇÏ´Â °¡¿îµ¥ 5G ±â¼úÀ» È¿°úÀûÀ¸·Î Ȱ¿ëÇÏ´Â ±â¾÷Àº Çö´ë ÀǷḦ º¯ÇõÇÏ´Â µ¥ ¾ÕÀå¼³ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 8¾ï676¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 9¾ï 9,110¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 34¾ï 2,084¸¸ ´Þ·¯
CAGR(%) 22.92%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °í¼Ó ³×Æ®¿öÅ· ±â¼úÀÇ ´ëµÎ¿Í ÇコÄɾ¼­ ¸ð¹ÙÀÏ Ç÷§ÆûÀÇ º¸±Þ È®´ë
    • ÀÀ±Þ Á¤º¸ ½Ã½ºÅÛ°ú ¿ø°Ý ÀÇ·á ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • µðÁöÅÐ Çコ ÃßÁøÀ» ÇâÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêÀÇ °íÁ¶
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀÇ·á Á¾»çÀÚÀÇ ÀÎ½Ä ºÎÁ·°ú IoT ±â¼ú ½ºÅ³ÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ½ÃÀå¿¡¼­ ½ÅÁ¦Ç°ÀÇ ¹ß¸Å¿Í ÇÔ²²ÀÇ ±â¼ú Áøº¸ÀÇ ÃâÇö
    • Àڱ⠿î¿ëÇü eÇコ Ç÷§Æû¿¡ÀÇ ÀÇÁ¸µµ Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • µ¥ÀÌÅÍ º¸¾È ¹®Á¦¿Í »óÈ£ ¿î¿ë¼º¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : 5G Áö¿ø ÀÇ·á±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº 5G Áö¿ø ÀÇ·á±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ½ÇÀûÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : 5G ȣȯ ÀÇ·á±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â 5G Áö¿ø ÀÇ·á±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â, ½ÇÀû ÁöÇ¥¸¦ Àç°ËÅäÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ƯÁ¤ÇØ, °³¼±¿¡ ÀÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï Á¤¼¼ÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÎ±â À§ÇÑ Ã¼Á¦¸¦ °®Ãâ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÇコÄɾ¼­ °í¼Ó ³×Æ®¿öÅ© ±â¼úÀÇ ´ëµÎ¿Í ¸ð¹ÙÀÏ Ç÷§ÆûÀÇ º¸±Þ È®´ë
      • ±ä±ÞÁ¤º¸ ½Ã½ºÅÛ°ú ¿ø°ÝÀÇ·á ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
      • µðÁöÅÐ Çコ¸¦ ÃßÁøÇÏ´Â Á¤ºÎÀÇ ´ëó°¡ ±ÞÁõ
    • ¾ïÁ¦¿äÀÎ
      • IoT ±â¼ú¿¡ ´ëÇÑ ÀÎ½Ä ºÎÁ·°ú ½ºÅ³ ºÎÁ·
    • ±âȸ
      • ±â¼úÀÇ Áøº¸¿Í ½ÃÀå¿¡ ½ÅÁ¦Ç° ÅõÀÔÀÇ À¶ÇÕ
      • ÀÚ¹ßÀûÀ¸·Î ¿î¿µÇÏ´Â eÇコ Ç÷§Æû¿¡ ´ëÇÑ ÀÇÁ¸µµ Áõ°¡
    • °úÁ¦
      • µ¥ÀÌÅÍ º¸¾È ¹®Á¦¿Í »óÈ£ ¿î¿ë¼º¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀå : À¯Çüº°

  • ³»ÀåÇü ±â±â
  • ÀÇ·á¿ë È­»ó ±â±â
  • ¿þ¾î·¯ºí ±â±â

Á¦7Àå 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀå : ¿ëµµº°

  • Ä¿³ØÆ¼µå ±¸±ÞÂ÷
  • HD °¡»ó ÄÁ¼³Å×À̼Ç
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ
  • ºñµð¿À ´ëÀÀ ó¹æÀü °ü¸®

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ 5G ´ëÀÀ ÀÇ·á±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • AT&T Inc.
  • BioIntelliSense, Inc.
  • Cisco Systems, Inc.
  • Fibocom Wireless Inc.
  • Huawei Technologies Co., Ltd.
  • Intel Corporation
  • International Business Machines Corporation
  • Johnson & Johnson Innovation LLC
  • Koninklijke Philips NV
  • Medtronic PLC
  • Nike, Inc.
  • Nokia Corporation
  • Oracle Corporation
  • Qualcomm Technologies, Inc.
  • Samsung Electronics Co., Ltd.
  • Siemens Healthineers
  • Sierra Wireless
  • Telefonaktiebolaget LM Ericsson
  • T-Mobile USA, Inc.
  • Verizon
AJY 24.12.06

The 5G-enabled Medical Devices Market was valued at USD 806.76 million in 2023, expected to reach USD 991.10 million in 2024, and is projected to grow at a CAGR of 22.92%, to USD 3,420.84 million by 2030.

5G-enabled medical devices represent a transformative leap in the healthcare sector, integrating cutting-edge telecommunications into medical practice. These devices leverage the speed, low latency, and high connectivity of 5G networks to enhance remote monitoring, telemedicine, robotic surgeries, and real-time data analytics, thereby facilitating instantaneous patient care and more precise medical interventions. The necessity for 5G-enabled medical devices stems from the increasing demand for efficient healthcare solutions that can cater to aging populations, manage chronic diseases, and improve response times in critical situations. The application scope encompasses hospitals, clinics, ambulatory surgical centers, and home healthcare settings, leveraging devices such as connected implants, portable diagnostics, and wearables. Key growth drivers include technological advancements, increasing digital health solutions, and the rising investment from both public and private sectors toward healthcare digitization. Opportunities lie in expanding telehealth services, personalized medicine, and AI-driven diagnostics, which can be augmented using 5G technologies. However, challenges such as high costs, data privacy concerns, and infrastructural limitations can impede growth. Additionally, the regulatory landscape remains complex, with varied standards across regions that can hinder swift adoption. Innovation and research can focus on enhancing interoperability, developing more efficient battery solutions for mobile devices, and creating robust cybersecurity protocols to protect sensitive patient information. The market is dynamic and poised for growth, driven by regulatory support and the overarching trend towards digital transformation in healthcare. Companies can capitalize by investing in strategic partnerships and collaborative ecosystems to drive innovation and by focusing on regions with developing 5G infrastructure. As healthcare moves toward a more networked and data-driven industry, businesses that harness 5G technology effectively will lead the charge in transforming modern medical practice.

KEY MARKET STATISTICS
Base Year [2023] USD 806.76 million
Estimated Year [2024] USD 991.10 million
Forecast Year [2030] USD 3,420.84 million
CAGR (%) 22.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 5G-enabled Medical Devices Market

The 5G-enabled Medical Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising high-speed networking technologies and increasing penetration of mobile platforms in healthcare
    • Increasing demand for emergency information systems and telehealth systems
    • Surging government initiatives for promoting digital health
  • Market Restraints
    • Lack of awareness and insufficient IoT technology skills among
  • Market Opportunities
    • Emergence of technological advancements coupled with new product launches in the market
    • Increased dependency on self-operated eHealth platforms
  • Market Challenges
    • Concerns regarding data security issues and interoperability

Porter's Five Forces: A Strategic Tool for Navigating the 5G-enabled Medical Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 5G-enabled Medical Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 5G-enabled Medical Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 5G-enabled Medical Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 5G-enabled Medical Devices Market

A detailed market share analysis in the 5G-enabled Medical Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 5G-enabled Medical Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 5G-enabled Medical Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 5G-enabled Medical Devices Market

A strategic analysis of the 5G-enabled Medical Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 5G-enabled Medical Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AT&T Inc., BioIntelliSense, Inc., Cisco Systems, Inc., Fibocom Wireless Inc., Huawei Technologies Co., Ltd., Intel Corporation, International Business Machines Corporation, Johnson & Johnson Innovation LLC, Koninklijke Philips N.V., Medtronic PLC, Nike, Inc., Nokia Corporation, Oracle Corporation, Qualcomm Technologies, Inc., Samsung Electronics Co., Ltd., Siemens Healthineers, Sierra Wireless, Telefonaktiebolaget LM Ericsson, T-Mobile USA, Inc., and Verizon.

Market Segmentation & Coverage

This research report categorizes the 5G-enabled Medical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Implantable Devices, Medical Imaging Equipment, and Wearable Devices.
  • Based on Application, market is studied across Connected Ambulance, HD virtual Consultations, Remote Patient Monitoring, and Video-Enabled Prescription Management.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising high-speed networking technologies and increasing penetration of mobile platforms in healthcare
      • 5.1.1.2. Increasing demand for emergency information systems and telehealth systems
      • 5.1.1.3. Surging government initiatives for promoting digital health
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness and insufficient IoT technology skills among
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of technological advancements coupled with new product launches in the market
      • 5.1.3.2. Increased dependency on self-operated eHealth platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding data security issues and interoperability
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. 5G-enabled Medical Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Implantable Devices
  • 6.3. Medical Imaging Equipment
  • 6.4. Wearable Devices

7. 5G-enabled Medical Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Connected Ambulance
  • 7.3. HD virtual Consultations
  • 7.4. Remote Patient Monitoring
  • 7.5. Video-Enabled Prescription Management

8. Americas 5G-enabled Medical Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific 5G-enabled Medical Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa 5G-enabled Medical Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AT&T Inc.
  • 3. BioIntelliSense, Inc.
  • 4. Cisco Systems, Inc.
  • 5. Fibocom Wireless Inc.
  • 6. Huawei Technologies Co., Ltd.
  • 7. Intel Corporation
  • 8. International Business Machines Corporation
  • 9. Johnson & Johnson Innovation LLC
  • 10. Koninklijke Philips N.V.
  • 11. Medtronic PLC
  • 12. Nike, Inc.
  • 13. Nokia Corporation
  • 14. Oracle Corporation
  • 15. Qualcomm Technologies, Inc.
  • 16. Samsung Electronics Co., Ltd.
  • 17. Siemens Healthineers
  • 18. Sierra Wireless
  • 19. Telefonaktiebolaget LM Ericsson
  • 20. T-Mobile USA, Inc.
  • 21. Verizon
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦